Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Di Perri

Showing results (111-120 of 177) with videos related to

Pageof 18
Sort By:
Journal of Viral Hepatitis|March 16, 2013
Sequential therapy with entecavir and PEG-INF in patients affected by chronic hepatitis B and high levels of HBV-DNA with non-D genotypesL Boglione, A D'Avolio, G Cariti, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 7, 2015
Relationship between the early boceprevir-S isomer plasma concentrations and the onset of breakthrough during HCV genotype 1 triple therapyL Boglione, A De Nicolò, C S Cardellino, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 14, 1997
Microsporidium species in pulmonary cavitary lesions of AIDS patients infected with Rhodococcus equiM Lanzafame, S Bonora, G Di Perri, et al.
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 1, 1996
Comparative histopathological study of pulmonary tuberculosis in human immunodeficiency virus-infected and non-infected patientsG Di Perri, A Cazzadori, S Vento, et al.
HIV Medicine|March 9, 2016
The role of tenofovir alafenamide in future HIV managementA Antela, C Aguiar, J Compston, et al.
The Journal of Antimicrobial Chemotherapy|January 15, 2005
Pharmacokinetics and hepatotoxicity of lopinavir/ritonavir in non-cirrhotic HIV and hepatitis C virus (HCV) co-infected patientsF Canta, R Marrone, S Bonora, et al.
The Journal of Antimicrobial Chemotherapy|August 10, 2000
Concentrations of single-dose meropenem (1 g iv) in bronchoalveolar lavage and epithelial lining fluidB Allegranzi, A Cazzadori, G Di Perri, et al.
The Journal of Antimicrobial Chemotherapy|March 27, 2020
Antiretroviral concentrations in the presence and absence of valproic acidA Calcagno, J Cusato, M Ferrara, et al.
The Journal of Antimicrobial Chemotherapy|October 22, 2010
Posaconazole cerebrospinal concentrations in an HIV-infected patient with brain mucormycosisA Calcagno, L Baietto, F G De Rosa, et al.
Journal of Clinical Microbiology|September 17, 1999
Comparative evaluation of ligation-mediated PCR and spoligotyping as screening methods for genotyping of Mycobacterium tuberculosis strainsS Bonora, M C Gutierrez, G Di Perri, et al.
Pageof 18

Showing results (111-120 of 177) with videos related to

Sort By:
Pageof 18
Journal of Viral Hepatitis|March 16, 2013
Sequential therapy with entecavir and PEG-INF in patients affected by chronic hepatitis B and high levels of HBV-DNA with non-D genotypesL Boglione, A D'Avolio, G Cariti, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 7, 2015
Relationship between the early boceprevir-S isomer plasma concentrations and the onset of breakthrough during HCV genotype 1 triple therapyL Boglione, A De Nicolò, C S Cardellino, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 14, 1997
Microsporidium species in pulmonary cavitary lesions of AIDS patients infected with Rhodococcus equiM Lanzafame, S Bonora, G Di Perri, et al.
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 1, 1996
Comparative histopathological study of pulmonary tuberculosis in human immunodeficiency virus-infected and non-infected patientsG Di Perri, A Cazzadori, S Vento, et al.
HIV Medicine|March 9, 2016
The role of tenofovir alafenamide in future HIV managementA Antela, C Aguiar, J Compston, et al.
The Journal of Antimicrobial Chemotherapy|January 15, 2005
Pharmacokinetics and hepatotoxicity of lopinavir/ritonavir in non-cirrhotic HIV and hepatitis C virus (HCV) co-infected patientsF Canta, R Marrone, S Bonora, et al.
The Journal of Antimicrobial Chemotherapy|August 10, 2000
Concentrations of single-dose meropenem (1 g iv) in bronchoalveolar lavage and epithelial lining fluidB Allegranzi, A Cazzadori, G Di Perri, et al.
The Journal of Antimicrobial Chemotherapy|March 27, 2020
Antiretroviral concentrations in the presence and absence of valproic acidA Calcagno, J Cusato, M Ferrara, et al.
The Journal of Antimicrobial Chemotherapy|October 22, 2010
Posaconazole cerebrospinal concentrations in an HIV-infected patient with brain mucormycosisA Calcagno, L Baietto, F G De Rosa, et al.
Journal of Clinical Microbiology|September 17, 1999
Comparative evaluation of ligation-mediated PCR and spoligotyping as screening methods for genotyping of Mycobacterium tuberculosis strainsS Bonora, M C Gutierrez, G Di Perri, et al.
Pageof 18